HOXB13 and Familial prostate cancer: When we stratified by cancer type, there is significant heterogeneity was existed (I2 = 68.4%, Pheterogeneity < 0.0001) and then random-effect models was used to verify the relationship between HOXB13 p.Gly84Glu mutation and prostate cancer risk.